Patents
Patents for C07K 19 - Hybrid peptides (29,428)
01/2010
01/21/2010WO2009145489A3 Cell-permeable endostatin recombinant protein, a polynucleotide coated with the same, and an anti-cancer preparation containing the same as an active component
01/21/2010WO2009130612A3 Prion epitopes and methods of use thereof
01/21/2010WO2004024097A9 Compositions and methods for the treatment of immune related diseases
01/21/2010WO2003006609A9 Human cytokine receptor
01/21/2010US20100017914 Insecticidal proteins
01/21/2010US20100016562 Reducing the immunogenicity of fusion proteins
01/21/2010US20100016227 Ligand/lytic peptide compositions and methods of use
01/21/2010US20100015173 Coiled-coil lipopeptide helical bundles and synthetic virus-like particles
01/21/2010US20100015166 Therapeutic antibodies
01/21/2010US20100015096 Fusion Proteins of Mycobacterium Tuberculosis
01/21/2010US20100015089 Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation
01/21/2010US20100015056 Uranium-chelating peptides and uses thereof
01/21/2010CA2731216A1 Compositions for the detection and treatment of colorectal cancer
01/21/2010CA2731194A1 Chimeric respiratory syncytial virus polypeptide antigens
01/21/2010CA2731086A1 Non-invasive fetal rhd genotyping from maternal whole blood
01/21/2010CA2730996A1 Long-acting interferons and derivatives thereof and methods thereof
01/21/2010CA2730933A1 Recombinant pokeweed antiviral proteins, compositions and methods related thereto
01/20/2010EP2144924A1 Fusion protein vaccine
01/20/2010EP1861418B1 T cd4+ epitopes of type i and ii latency antigens of the epstein-barr virus, which can be recognised by the majority of individuals in the caucasian population and applications thereof
01/20/2010EP1507869B1 Improved receptor detection
01/20/2010CN101628942A Recombinant fusion protein based on human TMPD1 and HMGB1 A box and preparation method thereof
01/20/2010CN101628941A Bovine lactoferrin antibacterial peptide fusion protein, coding gene and application thereof
01/20/2010CN101628111A TACI-immunoglobulin fusion proteins
01/20/2010CN100582122C O-type foot-and-mouth disease virus multi-epitope mucous membrane immunization vaccine and use
01/19/2010US7649084 Genetic engineering; cat thyrotropin beta -subunit polypeptide and polynucleotide; hyperthyroidism
01/19/2010US7648701 Peptide composition as immunogen for the treatment of allergy
01/19/2010CA2123492C Lymphoid antigen cd30
01/14/2010WO2010005389A1 Oxidized ldl specific antibody-fusion and conjugated proteins
01/14/2010WO2010004292A1 Chimaeric peptide
01/14/2010WO2010003240A1 Gmcsf and truncated ccl2 conjugates and methods and uses thereof
01/14/2010WO2010003235A1 Soluble recombinant influenza antigens
01/14/2010US20100010200 for Systemic Inflammatory Response Syndrome (SIRS), including severe sepsis, septic shock and sepsis related to cardiac dysfunction
01/14/2010US20100010195 Novel tumor necrosis factor receptor homolog and nucleic acids encoding the same
01/14/2010US20100009439 ANTI-IGF-I RECEPTOR ANTIBODIES, DNAs, VECTORS, HOST CELLS AND GENETIC CONSTRUCTS
01/14/2010CA2730171A1 Soluble recombinant influenza antigens
01/14/2010CA2729351A1 Fn14/trail fusion proteins
01/13/2010EP2143732A1 T1R1 Taste receptors and genes encoding same
01/13/2010EP2143731A1 Compounds for immunotherapy of prostate cancer and methods for their use
01/13/2010EP2143438A1 Compositions and methods for the diagnosis and treatment of tumor
01/13/2010EP2143437A1 Compositions and methods for the diagnosis and treatment of tumor
01/13/2010EP2142572A1 Tgfp-cap peptide and its uses
01/13/2010EP1692162B1 Tool for the transfer and production of proteins using the pseudomonas type iii secretion system
01/13/2010EP1394253B1 Anti-human ovarian cancer -anti-cd3 bispecific antibody
01/13/2010CN100580084C Combinatorial libraries of proteins having the scaffold structure of C-type lectin-like domains
01/13/2010CN100579989C Interfusion protein between diphtheria toxin and GM-CSF mutant, coded gene and application
01/13/2010CN100579988C Interfusion protein between diphtheria toxin and GM-CSF mutant, coded gene and application
01/13/2010CN100579987C Liver target fusion protein with siRNA guiding effect
01/13/2010CN100579986C Production method of insulinotropic secretion peptide GLP-1(7-36) and GLP-1 analog
01/12/2010CA2443365C Methods for the recombinant production of antifusogenic peptides
01/12/2010CA2438143C Modified proteins, designer toxins, and methods of making thereof
01/12/2010CA2340974C Method for purifying proteins and/or biomolecule or protein complexes
01/12/2010CA2300360C Novel antigen constructs useful in the detection and differentiation of antibodies to hiv
01/07/2010WO2010002478A2 Glycopeptide and uses thereof
01/07/2010WO2010000758A1 Method for optimizing proteins having the folding pattern of immunoglobulin
01/07/2010WO2010000675A1 Polypeptides, cyclic polypeptides and pharmaceutical compositions comprising thereof for inhibiting activity of trkb
01/07/2010US20100003267 Anti-angiogenic compounds
01/07/2010US20100003259 Antibodies that immunospecifically bind to b lymphocyte stimulator protein
01/07/2010CA2729749A1 Tnf-a antagonist multi-target binding proteins
01/07/2010CA2729591A1 Method for optimizing proteins having the folding pattern of immunoglobulin
01/06/2010EP2141243A2 Protein scaffolds for antibody mimics and other binding proteins
01/06/2010EP2139883A2 Hiv-1 protease inhibitors
01/06/2010EP2139525A1 Fusion protein capable of degrading amyloid beta peptide
01/06/2010EP1135468B1 Virus vectors and methods of making and administering the same
01/05/2010US7642345 Polynucleotides encoding human cytokine receptor
01/05/2010US7642228 Method for making heteromultimeric polypeptides
01/05/2010US7641901 Immunotherapy of autoimmune disorders using antibodies which target B-cells
01/05/2010US7641899 Methods for inhibiting IL-TIF-induced proliferation of hematopoietic cells using the cytokine receptor Zcytor16
01/05/2010CA2456183C Il-6/ds-sil-6r fusion protein
01/05/2010CA2369884C Transiently immortalized cells for use in gene therapy
01/05/2010CA2332642C Method for producing or enhancing a t-cell response against a target cell using a complex comprising an hla class i molecule and an attaching means
01/05/2010CA2281877C Psca: prostate stem cell antigen
12/2009
12/31/2009US20090325880 Tnf receptor-like molecules and uses thereof
12/31/2009US20090325815 Production of anti-self antibodies from antibody segment repertoires and displayed on phage
12/31/2009US20090324599 activates FGF receptors, regulates the growth and differentiation of cells within the liver, regulates other cell types following secretion from the liver, plays a role in liver chemotaxis, has an oncogenic activity, or serves as an antigen for generating antibodies; treating diabetes or obesity
12/30/2009WO2009158729A2 Compounds and methods for diagnosis and treatment of chagas disease
12/30/2009WO2009155842A1 Fusion protein of onconase and toxin transmembrane domain and preparation method and use thereof
12/30/2009WO2009155789A1 Polypeptides and derivatives thereof that inhibit hiv infection
12/30/2009EP2138576A1 Anti-claudin-4 antibody
12/30/2009EP2137305A1 Engineered versions of cgtb (beta-1,3- galactosyltransferase) enzymes, with enhanced enzymatic properties
12/30/2009EP2137213A1 Methods and compositions for treating prostate cancer
12/30/2009EP1504037B1 Ferritin fusion proteins for use in vaccines and other applications
12/30/2009EP1438325B1 Isolated dna molecules encoding humanized calcitonin gene-related peptide receptor, related non-human transgenic animals and assay methods
12/30/2009CN101613410A Fusion protein of ribonuclease and toxalbumin membrane transposition structural domain, preparation and application thereof
12/30/2009CN100575493C Supersecretable peptides, processes for their production, and parallel improvement of the secreted form of one or more other polypeptides
12/30/2009CN100575482C Novel cytokine zcytor17 ligand
12/30/2009CA2726894A1 Therapeutic agents comprising elastin-like peptides
12/29/2009US7638602 Heterodimeric human cytokine receptor comprising Zcytor16/Zcytor11 components for use in treatment of cell proliferative, inflammatory and immune disorders
12/29/2009US7638480 Use of osteoprotegerin for the treatment and/or prevention of fibrotic disease
12/29/2009US7638327 polypeptides related to a receptor to BAFF (a B-cell activating factor belonging to the Tumor Necrosis Factor family, which is associated with expression of B-cells and immunoglobulins); treatment of cancers, lymphomas, autoimmune diseases related to B-cells
12/29/2009US7638323 for treating or preventing hyperacute rejection; solid phase synthesis; genetic engineering
12/29/2009US7638289 Human T2R55 taste receptor and related assays for identifying human bitter taste modulators
12/29/2009CA2189848C Photocleavable agents and conjugates for the detection and isolation of biomolecules
12/29/2009CA2153507C A fas ligand, a fragment thereof and dna encoding the same
12/24/2009US20090318352 Materials and Methods Involving Hybrid Vascular Endothelial Growth Factor DNAs and Proteins
12/24/2009US20090317868 Rapidly Cleavable Sumo Fusion Protein Expression System for Difficult to Express Proteins
12/24/2009US20090317398 a labeled polyclonal antibody, monoclonal antibody or antigen-binding fragment which preferentially binds to a polypeptide that chemoattracts peripheral blood monocytes or T-cells; proteins which control development, differentiation, trafficking and physiology of mammalian cells; immunology
12/24/2009US20090317389 Fusion molecules and methods for treatment of immune diseases
12/24/2009US20090317379 Autophilic antibodies and method of making the same
12/24/2009US20090317368 B7-h1, a novel immunoregulatory molecule
12/23/2009WO2009154804A2 Twin fluorophore peptide nucleic acid hybridization probes
1 ... 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 ... 295